Cellectis S.A.

Cellectis S.A.verified

ALCLS.PA

Price:

$1.668

Market Cap:

$131.04M

Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316 for the treatment of Renal Cell Carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART22 to treat B-cell acute lymphoblastic leuke...[Read more]

Industry

Biotechnology

IPO Date

2007-02-07

Stock Exchange

EURONEXT

Ticker

ALCLS.PA

The Current Ratio as of December 2024 (TTM) for Cellectis S.A. (ALCLS.PA) is 1.78

According to Cellectis S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 1.78. This represents a change of 4.17% compared to the average of 1.71 of the last 4 quarters.

Cellectis S.A. (ALCLS.PA) Historical Current Ratio (quarterly & annually)

How has ALCLS.PA Current Ratio performed in the past?

The mean historical Current Ratio of Cellectis S.A. over the last ten years is 5.02. The current 1.78 Current Ratio has changed 3.44% with respect to the historical average. Over the past ten years (40 quarters), ALCLS.PA's Current Ratio was at its highest in in the June 2018 quarter at 12.49. The Current Ratio was at its lowest in in the December 2023 quarter at 1.50.

Quarterly (TTM)
Annual

Average

5.02

Median

5.07

Minimum

1.50

Maximum

10.40

Cellectis S.A. (ALCLS.PA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cellectis S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 146.37%

Maximum Annual Current Ratio = 10.40

Minimum Annual Increase = -50.03%

Minimum Annual Current Ratio = 1.50

Quarterly (TTM)
Annual
YearCurrent RatioChange
20231.50-34.21%
20222.28-50.03%
20214.57-24.65%
20206.06-3.05%
20196.25-39.89%
201810.4040.13%
20177.4233.46%
20165.5628.07%
20154.34146.37%
20141.76106.15%

Cellectis S.A. (ALCLS.PA) Average Current Ratio

How has ALCLS.PA Current Ratio performed in the past?

The current Current Ratio of Cellectis S.A. (ALCLS.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.78

5-year avg

4.13

10-year avg

5.02

Cellectis S.A. (ALCLS.PA) Current Ratio vs. Peers

How is ALCLS.PA’s Current Ratio compared to its peers?

Cellectis S.A.’s Current Ratio is less than Innate Pharma S.A. (2.92), less than Genfit S.A. (3.74), greater than Nanobiotix S.A. (1.42), greater than Adocia SA (0.92), less than DBV Technologies S.A. (2.22),

CompanyCurrent RatioMarket cap
2.92$157.29M
3.74$175.76M
1.42$151.89M
0.92$110.39M
2.22$67.68M

Build a custom stock screener for Cellectis S.A. (ALCLS.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectis S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellectis S.A. (ALCLS.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellectis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Cellectis S.A.'s Current Ratio?

How is the Current Ratio calculated for Cellectis S.A. (ALCLS.PA)?

What is the highest Current Ratio for Cellectis S.A. (ALCLS.PA)?

What is the 3-year average Current Ratio for Cellectis S.A. (ALCLS.PA)?

What is the 5-year average Current Ratio for Cellectis S.A. (ALCLS.PA)?

How does the current Current Ratio for Cellectis S.A. (ALCLS.PA) compare to its historical average?